Range Cancer Therapeutics ETF - USD Stock

ETF

CNCR

US26922A8264

Market Closed - Nasdaq 04:15:00 2024-05-10 pm EDT 5-day change 1st Jan Change
14.86 USD -2.49% Intraday chart for Range Cancer Therapeutics ETF - USD -6.31% +10.32%
Current month+0.68%
1 month-4.44%
Dynamic Chart

Investment objective

The Loncar Cancer Immunotherapy ETF trades on Nasdaq under the symbol CNCR. It is made of up a basket of companies that develop therapies to treat cancer by harnessing the body's own immune system. Immunotherapy is a transformational field within the biotechnology space that may have a foundational impact on cancer care. By developing immunotherapies that are more effective and deliver a better quality of life than currently available medicines, innovative immunotherapy companies may be making a difference for courageous patients who battle cancer. Our fund seeks to support this important work and its positive impact on society. It tracks the LCINDX index.
Name
Price
Change
5d. change
1st Jan change
Weight
8.12 USD +0.74%-11.26%+61.75%2.84%
37.25 USD -0.53%-7.34%+29.88%2.32%
3.99 USD -4.32%-4.77%-38.04%2.27%
3.31 USD -77.44%-78.88%-65.59%2.09%
106.7 USD -1.51%-0.46%+15.68%1.77%
4.08 USD +4.62%+0.49%+9.09%1.76%
49.74 USD -5.67%-5.60%-10.38%1.69%
31.44 USD -1.60%-4.20%-23.62%1.69%
See all (82)
In partnership with
TrackInsight
Date Price Change Volume
24-05-10 14.86 -2.49% 4,718
24-05-09 15.24 -1.42% 4,504
24-05-08 15.46 -2.09% 2,779
24-05-07 15.79 +0.32% 961
24-05-06 15.74 -0.76% 4,478

Delayed Quote Nasdaq

Last update May 10, 2024 at 04:15 pm EDT

More quotes

Description

US26922A8264
Total Expense Ratio 0.79%
Asset Class
Sector
Size
Currency
Provider
Underlying Range Oncology Therapeutics Index - USD

Features and characteristics

Jurisdiction
Fund Structure
Replication Method
Replication Model
Date of creation
2015-03-17
Dividend Policy
Geographical Focus

Distribution

Retail investor

AuM evolution ( 2024-04-29 )

AuM (EUR) 0 M€
AuM 1M 0 M€
AuM 3 months 0 M€
AuM 6 months 0 M€
AuM 12 months 0 M€
  1. Stock Market
  2. ETF
  3. CNCR ETF
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW